Recent findings also suggest that a loss-of-function variant in the hydroxysteroid 17 beta dehydrogenase 13 (HSD17B13) gene may reduce the risk of chronic liver disease and the progression from steatosis to steatohepatitis, potentially affecting HCC development [86]. Here, HSD17B13 is linked to hepatocellular carcinoma.